Rosemary inhalation improves the behavior and cognition of vascular cognitive impairment rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy

Articles in Press

Document Type : Original Article

Authors

Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China

10.22038/ijbms.2026.91451.19757

Abstract

Objective(s): Vascular cognitive impairment (VCI) is a major cause of behavioral and cognitive abnormalities and dementia, but there are currently no specific drugs for VCI. Rosemary oil has been found to have a role in cognitive function. This study aims to evaluate whether inhalation of rosemary can improve learning and memory in VCI rats by regulating neuronal apoptosis and autophagy.
Materials and Methods: Male SD rats were used to establish a VCI rat model by bilateral common carotid artery ligation. The rats were intervened with rosemary essential oil inhalation and EX527 injection. Cognitive function was evaluated by the Morris water maze test two weeks after the operation. The pathological changes of hippocampal tissue (HE, Nissl, TEM, TUNEL) and protein expression (WB) were analyzed.
Results: Compared with the sham group, the VCI group exhibited cognitive deficits, neuronal loss, mitochondrial damage, and increased neuronal apoptosis (P<0.001). The levels of caspase-3, LC3B, and p-mTOR/mTOR in the hippocampal tissue were significantly elevated (P<0.0001, P<0.01, P<0.01), while the protein level of SIRT1 was significantly reduced (P<0.01). Compared with the VCI group, the rosemary group showed improved cognitive ability, ameliorated neuronal damage, and reduced neuronal apoptosis (P<0.05). The levels of caspase-3, LC3B, and p-mTOR/mTOR were decreased (P<0.0001, P<0.01, P<0.05), while the level of SIRT1 was increased (P<0.05). However, intervention with EX527 attenuated this protective effect.
Conclusion: Rosemary inhalation can improve behavior and cognition in VCI rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy.

Keywords

Main Subjects

References

1. Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, et al. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement 2018; 14:280-292.
2. Medina-Rioja R, Patwardhan A, Mercado-Pompa A, Masellis M, Black SE. Ten things to remember (and not forget) about vascular cognitive impairment. Stroke 2024; 55:e29-e32.
3. Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ. Vascular cognitive impairment (VCI). Neurotherapeutics 2022; 19:68-88.
4. van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P. Vascular cognitive impairment. Nat Rev Dis Primers 2018; 4:18003.
5. Corriveau RA, Bosetti F, Emr M, Gladman JT, Koenig JI, Moy CS, et al. The science of vascular contributions to cognitive impairment and dementia (VCID): A framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol 2016; 36:281-288.
6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64:277-281.
7. You T, Wang Y, Chen S, Dong Q, Yu J, Cui M. Vascular cognitive impairment: Advances in clinical research and management. Chin Med J (Engl) 2024; 137:2793-2807.
8. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. The recognition, assessment and management of dementing disorders: Conclusions from the Canadian Consensus Conference on Dementia. Cmaj 1999; 160:S1-15.
9. Gitlin LN, Winter L, Burke J, Chernett N, Dennis MP, Hauck WW. Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: A randomized pilot study. Am J Geriatr Psychiatry 2008; 16:229-239.
10. Heinrich M, Kufer J, Leonti M, Pardo-de-Santayana M. Ethnobotany and ethnopharmacology--interdisciplinary links with the historical sciences. J Ethnopharmacol 2006; 107:157-160.
11. Zhang L, Lu J. Rosemary (Rosmarinus officinalis L.) polyphenols and inflammatory bowel diseases: Major phytochemicals, functional properties, and health effects. Fitoterapia 2024; 177:106074.
12. Bakirel T, Bakirel U, Keleş OU, Ulgen SG, Yardibi H. In vivo assessment of antidiabetic and anti-oxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol 2008; 116:64-73.
13. Sasaki K, El Omri A, Kondo S, Han J, Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav Brain Res 2013; 238:86-94.
14. Östreicher C, Gensberger-Reigl S, Pischetsrieder M. Targeted mass spectrometry to monitor nuclear accumulation of endogenous Nrf2 and its application to SH-SY5Y cells stimulated with food components. Anal Bioanal Chem 2019; 411:1273-1286.
15. Rasoolijazi H, Mehdizadeh M, Soleimani M, Nikbakhte F, Eslami Farsani M, Ababzadeh S. The effect of rosemary extract on spatial memory, learning and antioxidant enzymes activities in the hippocampus of middle-aged rats. Med J Islam Repub Iran 2015; 29:187.
16. Habtemariam S. Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for alzheimer’s and vascular dementia drugs. Int J Mol Sci 2018; 19:458.
17. Sivamaruthi BS, Kesika P, Sisubalan N, Chaiyasut C. The Role of Essential Oils on Sleep Quality and Other Sleep-related Issues: Evidence from Clinical Trials. Mini Rev Med Chem 2025; 25:234-258.
18. Yunlong D, Xiaoping G, Guangwu L. The effects of rosemary inhalation on learning and memory and hippocampal 5-hydroxytryptamine content in vascular dementia rats. Chin J Rehabil Med 2013; 28:657-659.
19. Fan Y, Wang Y, Ji W, Liu K, Wu H. Exercise preconditioning ameliorates cognitive impairment and anxiety-like behavior via regulation of dopamine in ischemia rats. Physiol Behav 2021; 233:113353.
20. Zhiying D, Jingxin L, Hui G, Jiwei T, Qian P. The effect of dexmedetomidine regulating Sirt1/FOXO1 mediated autophagy pathway on cognitive function in depressed rats. Chin J Pathophysiol 2022; 38:858-865.
21. Beheshti F, Hosseini M, Hashemzehi M, Soukhtanloo M, Khazaei M, Shafei MN. The effects of PPAR-γ agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats. Iran J Basic Med Sci 2019; 22:940-948.
22. Mirshafiei M, Yazdi A, Beheshti S. Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligaion-induced hepatic encephalopathy. Iran J Basic Med Sci 2023; 26:966-971.
23. Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics 2009; 9:173-179.
24. Okuda M, Fujita Y, Takada-Takatori Y, Sugimoto H, Urakami K. Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation. PLoS One 2020; 15:e0240378.
25. Naderali E, Nikbakht F, Ofogh SN, Rasoolijazi H. The role of rosemary extract in degeneration of hippocampal neurons induced by kainic acid in the rat: A behavioral and histochemical approach. J Integr Neurosci 2018; 17:19-25.
26. He Y, He T, Li H, Chen W, Zhong B, Wu Y, et al. Deciphering mitochondrial dysfunction: Pathophysiological mechanisms in vascular cognitive impairment. Biomed Pharmacother 2024; 174:116428.
27. Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J 2021; 40:e108863.
28. Chen W, Sun Y, Liu K, Sun X. Autophagy: A double-edged sword for neuronal survival after cerebral ischemia. Neural Regen Res 2014; 9:1210-1216.
29. Zou W, Song Y, Li Y, Du Y, Zhang X, Fu J. The role of autophagy in the correlation between neuron damage and cognitive impairment in rat chronic cerebral hypoperfusion. Mol Neurobiol 2018; 55:776-791.
30. Zou W, Song Y, Li Y, Du Y, Zhang X, Fu J. Erratum to: The role of autophagy in the correlation between neuron damage and cognitive impairment in rat chronic cerebral hypoperfusion. Mol Neurobiol 2018; 55:792.
31. Liu B, Tang J, Zhang J, Li S, Yuan M, Wang R. Autophagy activation aggravates neuronal injury in the hippocampus of vascular dementia rats. Neural Regen Res 2014; 9:1288-1296.
32. Schaaf MB, Keulers TG, Vooijs MA, Rouschop KM. LC3/GABARAP family proteins: Autophagy-(un)related functions. Faseb j 2016; 30:3961-3978.
33. Maiese K. The impact of aging and oxidative stress in metabolic and nervous system disorders: Programmed cell death and molecular signal transduction crosstalk. Front Immunol 2023; 14:1273570.
34. Sun Z, Zhao S, Suo X, Dou Y. Sirt1 protects against hippocampal atrophy and its induced cognitive impairment in middle-aged mice. BMC Neurosci 2022; 23:33.
35. Wang X, Jia J. Magnolol improves Alzheimer’s disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway. Biomed Pharmacother 2023; 161:114473.
36. Zhang X, Li Y, Wang Y, Zhuang Y, Ren X, Yang K, Ma W, Zhong M. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis. Biosci Rep 2020; 40:BSR20194030.
37. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9:459-470.
38. Zheng G, Wang L, Li X, Niu X, Xu G, Lv P. Rapamycin alleviates cognitive impairment in murine vascular dementia: The enhancement of mitophagy by PI3K/AKT/mTOR axis. Tissue Cell 2021; 69:101481.
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 17 June 2026

Files

Share

How to cite

Statistics